cyclohexanol has been researched along with Refractory Depression in 14 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 14 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Cao, L; Chen, J; Fang, Y; Hong, W; Peng, D; Wu, Z; Yuan, C; Zhang, C | 1 |
| Asarnow, JR; Birmaher, B; Brent, DA; Clarke, GN; Emslie, GJ; He, J; Hilton, R; Keller, MB; Mansoor, BM; Mayes, T; Porta, G; Rengasamy, M; Ryan, ND; Shamseddeen, W; Wagner, KD | 1 |
| Asarnow, JR; Birmaher, B; Brent, DA; Clarke, GN; Emslie, GJ; He, J; Hilton, RC; Keller, MB; Mansoor, B; Mayes, T; Porta, G; Rengasamy, M; Ryan, N; Shamseddeen, W; Wagner, KD | 1 |
| Birmaher, B; Brent, D; Clarke, G; Emslie, GJ; He, J; Hilton, R; Mansoor, B; Mayes, TL; Porta, G; Rengasamy, M; Ryan, N; Shamseddeen, W; Spirito, A; Wagner, KD | 1 |
| Ellis, N; Garcia, A; Nakama, H; O'Brien, K | 1 |
| Ait Tayeb, AEK; Becquemont, L; Corruble, E; Dutech, C; Ellul, P; Gressier, F; Hardy, P; Monfort, J; Verstuyft, C | 1 |
| Arnold, EB; De Nadai, AS; Geffken, GR; Lewin, AB; McNamara, JP; Reid, A; Storch, EA | 1 |
| Bostic, JQ | 1 |
| Asarnow, JR; Birmaher, B; Brent, DA; Clarke, G; Emslie, G; Keller, MB; Mayes, T; Porta, G; Ryan, ND; Shamseddeen, W; Wagner, KD | 1 |
| Dusetzina, SB; Ellis, AR; Farley, JF; Gaynes, BN; Hansen, RA; Miller, WC; Stürmer, T | 1 |
| Weder, N | 1 |
| Rubin, DH | 1 |
| Asarnow, JR; Birmaher, B; Brent, DA; Clarke, G; Dickerson, JF; Dietz, LJ; Emslie, G; Keller, M; Kennard, B; Lynch, FL; Mayes, T; McMakin, DL; Olino, TM; Porta, G; Ryan, ND; Shamseddeen, W; Spirito, A; Wagner, KD | 1 |
| Mattison, RE | 1 |
7 trial(s) available for cyclohexanol and Refractory Depression
| Article | Year |
|---|---|
Difference in remission in a Chinese population with anxious versus nonanxious treatment-resistant depression: a report of OPERATION study.
Topics: Adolescent; Adult; Aged; Antidepressive Agents; Anxiety Disorders; Buspirone; China; Comorbidity; Cyclohexanols; Depressive Disorder, Major; Depressive Disorder, Treatment-Resistant; Double-Blind Method; Female; Humans; Male; Middle Aged; Paroxetine; Remission Induction; Risperidone; Treatment Outcome; Venlafaxine Hydrochloride; Young Adult | 2013 |
The bi-directional relationship between parent-child conflict and treatment outcome in treatment-resistant adolescent depression.
Topics: Adolescent; Child; Cognitive Behavioral Therapy; Combined Modality Therapy; Conflict, Psychological; Cyclohexanols; Depressive Disorder, Treatment-Resistant; Female; Humans; Male; Parent-Child Relations; Selective Serotonin Reuptake Inhibitors; Treatment Outcome; Venlafaxine Hydrochloride | 2013 |
Impact of treatments for depression on comorbid anxiety, attentional, and behavioral symptoms in adolescents with selective serotonin reuptake inhibitor-resistant depression.
Topics: Adolescent; Anxiety; Attention Deficit and Disruptive Behavior Disorders; Behavioral Symptoms; Citalopram; Cognitive Behavioral Therapy; Combined Modality Therapy; Comorbidity; Cyclohexanols; Depressive Disorder, Treatment-Resistant; Fluoxetine; Humans; Paroxetine; Remission Induction; Selective Serotonin Reuptake Inhibitors; Severity of Illness Index; Treatment Outcome; Venlafaxine Hydrochloride | 2013 |
The bidirectional relationship between body mass index and treatment outcome in adolescents with treatment-resistant depression.
Topics: Adolescent; Antidepressive Agents, Second-Generation; Body Mass Index; Child; Citalopram; Cyclohexanols; Depressive Disorder, Treatment-Resistant; Female; Fluoxetine; Humans; Male; Paroxetine; Selective Serotonin Reuptake Inhibitors; Treatment Outcome; Venlafaxine Hydrochloride | 2013 |
Treatment-resistant depressed youth show a higher response rate if treatment ends during summer school break.
Topics: Adolescent; Cognitive Behavioral Therapy; Combined Modality Therapy; Cyclohexanols; Depressive Disorder, Treatment-Resistant; Double-Blind Method; Female; Humans; Male; Psychiatric Status Rating Scales; Selective Serotonin Reuptake Inhibitors; Social Adjustment; Time Factors; Treatment Outcome; Venlafaxine Hydrochloride | 2011 |
Treating depression after initial treatment failure: directly comparing switch and augmenting strategies in STAR*D.
Topics: Adolescent; Adult; Aged; Antidepressive Agents, Second-Generation; Bupropion; Buspirone; Citalopram; Cyclohexanols; Depressive Disorder, Major; Depressive Disorder, Treatment-Resistant; Dose-Response Relationship, Drug; Drug Administration Schedule; Drug Substitution; Drug Therapy, Combination; Female; Humans; Likelihood Functions; Male; Middle Aged; Personality Inventory; Psychometrics; Quality of Life; Sertraline; United States; Venlafaxine Hydrochloride; Young Adult | 2012 |
Anhedonia predicts poorer recovery among youth with selective serotonin reuptake inhibitor treatment-resistant depression.
Topics: Adolescent; Affect; Anhedonia; Antidepressive Agents, Second-Generation; Cognitive Behavioral Therapy; Combined Modality Therapy; Cyclohexanols; Depressive Disorder, Major; Depressive Disorder, Treatment-Resistant; Double-Blind Method; Drug Resistance; Drug Substitution; Female; Humans; Longitudinal Studies; Male; Personality Assessment; Psychometrics; Psychotherapy; Selective Serotonin Reuptake Inhibitors; Venlafaxine Hydrochloride | 2012 |
7 other study(ies) available for cyclohexanol and Refractory Depression
| Article | Year |
|---|---|
Case report of a 24-year-old man with resolution of treatment-resistant major depressive disorder and comorbid PTSD using rTMS.
Topics: Antidepressive Agents, Second-Generation; Combat Disorders; Combined Modality Therapy; Cyclohexanols; Depressive Disorder, Major; Depressive Disorder, Treatment-Resistant; Diagnostic and Statistical Manual of Mental Disorders; Humans; Male; Military Personnel; Stress Disorders, Post-Traumatic; Transcranial Magnetic Stimulation; Venlafaxine Hydrochloride; Young Adult | 2014 |
Serotonin toxicity in a CYP2D6 poor metabolizer, initially diagnosed as a drug-resistant major depression.
Topics: Cyclohexanols; Cytochrome P-450 CYP2D6; Delayed-Action Preparations; Depressive Disorder, Treatment-Resistant; Genotype; Humans; Male; Middle Aged; Selective Serotonin Reuptake Inhibitors; Serotonin Syndrome; Venlafaxine Hydrochloride | 2014 |
Does cognitive-behavioral therapy response in youth with obsessive-compulsive disorder differ if treatment ends during summer?
Topics: Cognitive Behavioral Therapy; Cyclohexanols; Depressive Disorder, Treatment-Resistant; Female; Humans; Male; Selective Serotonin Reuptake Inhibitors | 2014 |
Summer is the best time for Treatment of Resistant Depression in Adolescents (TORDIA): the importance of school in medication trials.
Topics: Cognitive Behavioral Therapy; Cyclohexanols; Depressive Disorder, Treatment-Resistant; Female; Humans; Male; Selective Serotonin Reuptake Inhibitors; Venlafaxine Hydrochloride | 2011 |
Saving lives: can we predict and prevent adolescent suicide?
Topics: Anhedonia; Antidepressive Agents, Second-Generation; Cyclohexanols; Depressive Disorder, Major; Depressive Disorder, Treatment-Resistant; Female; Humans; Male; Selective Serotonin Reuptake Inhibitors; Venlafaxine Hydrochloride | 2012 |
Joy returns last: anhedonia and treatment resistance in depressed adolescents.
Topics: Anhedonia; Antidepressive Agents, Second-Generation; Cyclohexanols; Depressive Disorder, Major; Depressive Disorder, Treatment-Resistant; Female; Humans; Male; Selective Serotonin Reuptake Inhibitors; Venlafaxine Hydrochloride | 2012 |
School ratings in early-onset depression.
Topics: Cognitive Behavioral Therapy; Cyclohexanols; Depressive Disorder, Treatment-Resistant; Female; Humans; Male; Selective Serotonin Reuptake Inhibitors | 2012 |